Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.03M | 20.45M | 19.10M | 18.05M | 21.01M | 20.04M |
Gross Profit | 18.41M | 17.04M | 14.71M | 13.98M | 13.10M | 12.20M |
EBITDA | 8.62M | 7.61M | 7.11M | 5.38M | 5.41M | 2.62M |
Net Income | 6.76M | 5.96M | 5.59M | 4.00M | 4.12M | 1.59M |
Balance Sheet | ||||||
Total Assets | 54.83M | 51.60M | 50.58M | 49.32M | 55.05M | 53.43M |
Cash, Cash Equivalents and Short-Term Investments | 28.13M | 25.15M | 23.99M | 21.46M | 24.07M | 20.35M |
Total Debt | 777.63K | 481.02K | 747.11K | 2.97M | 6.70M | 7.47M |
Total Liabilities | 5.91M | 4.74M | 4.70M | 6.42M | 9.91M | 10.85M |
Stockholders Equity | 48.92M | 46.85M | 45.88M | 42.90M | 45.14M | 42.58M |
Cash Flow | ||||||
Free Cash Flow | 8.75M | 6.89M | 7.96M | 6.05M | 5.08M | 3.55M |
Operating Cash Flow | 8.82M | 6.96M | 8.86M | 6.10M | 5.40M | 4.20M |
Investing Cash Flow | -45.85K | -100.71K | -903.19K | 1.32M | -318.87K | -650.42K |
Financing Cash Flow | -5.09M | -5.70M | -5.43M | -10.03M | -1.36M | -1.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $469.31M | 35.93 | 6.11% | ― | 7.76% | ― | |
75 Outperform | $609.10M | 160.14 | 1.94% | ― | 3.62% | -53.21% | |
72 Outperform | $358.95M | 59.16 | 14.17% | 0.37% | 9.73% | 22.33% | |
59 Neutral | $601.11M | ― | 48.46% | ― | -0.81% | 9.83% | |
59 Neutral | $414.11M | ― | -64.59% | ― | 5.33% | 58.41% | |
58 Neutral | $680.69M | ― | -46.57% | ― | -2.39% | -2961.26% | |
50 Neutral | C$2.92B | 1.79 | -63.12% | 2.58% | 11.24% | -12.42% |
On June 20, 2025, ReposiTrak, Inc. announced a quarterly cash dividend of $0.01815 per share, payable on August 14, 2025, to shareholders of record on June 30, 2025. The company also revealed a 10% increase in its quarterly dividend, raising it to $0.02 per share starting with the dividend payable on November 14, 2025, marking the third increase since the dividend’s inception. This move underscores ReposiTrak’s commitment to providing value to its shareholders and may enhance its attractiveness to investors.
The most recent analyst rating on (TRAK) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.
ReposiTrak reported a 16% increase in total revenue, reaching $5.9 million for the third fiscal quarter ended March 31, 2025, with a 27% rise in net income. The company attributes this growth to successful cross-selling across its business lines, particularly in traceability, compliance, and supply chain solutions. The onboarding of traceability customers has shifted from retailers to suppliers, expanding the company’s market potential. The company also redeemed preferred shares and declared a quarterly dividend, maintaining a strong cash position with no bank debt.
The most recent analyst rating on (TRAK) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.